DOASENSE GmbH -- Technology - DOASENSE -- Pioneering Point-of-Care Testing for DOACs

Go to content

Main menu:

DOASENSE Technology Image

Our Technologies


Our sophisticated technologies for assessing DOAC in urine provide meaningful data to health care professionals and consumers, all in an easy, rapid assessment process
DOASENSE Color Detection Scheme
 
  • DOASENSE has developed technologies for assessing the presence or absence of oral direct Factor Xa as well as Thrombin inhibitors in urine samples through specific colors

  • The colors (e.g. on dipsticks) can be identified by the naked eye within a few minutes

  • Different color combinations are used for Factor Xa and Thrombin inhibitors
DOASENSE Technology Animation
Divider

Our Data

Global Study Data (13 Centers), from:
Harenberg J, et al., Clin Chem Lab Med. 2016 Feb 1; 54(2):275-83
Study Data
Divider
Our Intellectual Property

DOASENSE has compiled and owns a broad portfolio of international intellectual property for protecting its proprietary approaches to DOACs testing.
Divider
NOTE: DOASENSE products are not yet available.


Back to content | Back to main menu